tiprankstipranks
Trending News
More News >
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (DE:2TZ)
FRANKFURT:2TZ
Germany Market

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (2TZ) Financial Statements

Compare
0 Followers

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Financial Overview

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S's market cap is currently €3.86B. The company's EPS TTM is €; its P/E ratio is ―; Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Currency in CNY

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Earnings and Revenue History

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Debt to Assets

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Cash Flow

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.